Hospice Of The Pines 13175 East State Route 169, Dewey, AZ, 86327 | |
(928) 632-0111 |
News Archive
While health officials have long suspected the link between obesity and soda consumption, research released today provides the first scientific evidence of the potent role soda and other sugar-sweetened beverages play in fueling California's expanding girth.
Many patients showing signs of dementia are quickly diagnosed with Alzheimer's disease when they might actually suffer from frontotemporal dementia, delaying the appropriate treatment for them.
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
St. Jude Medical, Inc., a global medical device company, today announced the launch of the VantageView™ System in the United States and Europe. The VantageView System is a state-of-the-art, high-definition (HD) monitor that eliminates the need for multiple monitors and enhances workflow by improving the visualization of critical case information in the electrophysiology (EP) lab.
› Verified 7 days ago
Name | Hospice Of The Pines |
---|---|
Location | 13175 East State Route 169, Dewey, Arizona |
Hospice ID | 031559 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
SSA county code | 120 |
News Archive
While health officials have long suspected the link between obesity and soda consumption, research released today provides the first scientific evidence of the potent role soda and other sugar-sweetened beverages play in fueling California's expanding girth.
Many patients showing signs of dementia are quickly diagnosed with Alzheimer's disease when they might actually suffer from frontotemporal dementia, delaying the appropriate treatment for them.
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
St. Jude Medical, Inc., a global medical device company, today announced the launch of the VantageView™ System in the United States and Europe. The VantageView System is a state-of-the-art, high-definition (HD) monitor that eliminates the need for multiple monitors and enhances workflow by improving the visualization of critical case information in the electrophysiology (EP) lab.
› Verified 7 days ago
NPI Number | 1245778323 |
Organization Name | Copper Basin Healthcare, Inc. |
Address | 13207 E State Route 169 Ste A Dewey, Arizona, 86327 |
Phone Number | (928)632-0111 |
News Archive
While health officials have long suspected the link between obesity and soda consumption, research released today provides the first scientific evidence of the potent role soda and other sugar-sweetened beverages play in fueling California's expanding girth.
Many patients showing signs of dementia are quickly diagnosed with Alzheimer's disease when they might actually suffer from frontotemporal dementia, delaying the appropriate treatment for them.
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
St. Jude Medical, Inc., a global medical device company, today announced the launch of the VantageView™ System in the United States and Europe. The VantageView System is a state-of-the-art, high-definition (HD) monitor that eliminates the need for multiple monitors and enhances workflow by improving the visualization of critical case information in the electrophysiology (EP) lab.
› Verified 7 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 97.2 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 100.0 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 91.3 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 99.5 | 97.3 |
Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 95.5 | 93.3 |
News Archive
While health officials have long suspected the link between obesity and soda consumption, research released today provides the first scientific evidence of the potent role soda and other sugar-sweetened beverages play in fueling California's expanding girth.
Many patients showing signs of dementia are quickly diagnosed with Alzheimer's disease when they might actually suffer from frontotemporal dementia, delaying the appropriate treatment for them.
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
St. Jude Medical, Inc., a global medical device company, today announced the launch of the VantageView™ System in the United States and Europe. The VantageView System is a state-of-the-art, high-definition (HD) monitor that eliminates the need for multiple monitors and enhances workflow by improving the visualization of critical case information in the electrophysiology (EP) lab.
› Verified 7 days ago
Home Health Aides | 6 |
Counselors | 3 |
Licensed Practical or Vocational Nurses | 3 |
Medical Social Workers | 3 |
Physicians | 3 |
Registered Nurses | 8 |
Other Personnel | 8 |
Total Employees | 34 |
---|
News Archive
While health officials have long suspected the link between obesity and soda consumption, research released today provides the first scientific evidence of the potent role soda and other sugar-sweetened beverages play in fueling California's expanding girth.
Many patients showing signs of dementia are quickly diagnosed with Alzheimer's disease when they might actually suffer from frontotemporal dementia, delaying the appropriate treatment for them.
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
St. Jude Medical, Inc., a global medical device company, today announced the launch of the VantageView™ System in the United States and Europe. The VantageView System is a state-of-the-art, high-definition (HD) monitor that eliminates the need for multiple monitors and enhances workflow by improving the visualization of critical case information in the electrophysiology (EP) lab.
› Verified 7 days ago
Others | 27 |
Total Volunteers | 27 |
---|
News Archive
While health officials have long suspected the link between obesity and soda consumption, research released today provides the first scientific evidence of the potent role soda and other sugar-sweetened beverages play in fueling California's expanding girth.
Many patients showing signs of dementia are quickly diagnosed with Alzheimer's disease when they might actually suffer from frontotemporal dementia, delaying the appropriate treatment for them.
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
St. Jude Medical, Inc., a global medical device company, today announced the launch of the VantageView™ System in the United States and Europe. The VantageView System is a state-of-the-art, high-definition (HD) monitor that eliminates the need for multiple monitors and enhances workflow by improving the visualization of critical case information in the electrophysiology (EP) lab.
› Verified 7 days ago
Hospice Of The Pines Location: 13175 East State Route 169, Dewey, Arizona, 86327 Phone: (928) 632-0111 |